| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-12 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.19 | 3e-07 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.18 | 7e-07 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.62 | 2e-05 |